Day: May 17, 2021

UltraCAR-T Therapy – Scope & Possibilities in Multiple Myeloma Management

Ongoing clinical trials are investigating the safety and efficacy of a new type of CAR T (Chimeric antigen receptor T-cells) therapy called UltraCAR-T therapy for myeloid malignancies. Unlike current CAR T cells, which utilize viruses to attach the CAR to…